Training grant in transfusion medicine

描述(由申请人提供)：这是一份续签的NRSA申请(T32 HL69769)，请求继续支持，以维持埃默里大学有效和富有成效的输血医学研究培训奖学金。输血医学的研究对该领域的未来至关重要，对下游世界各地接受输血和细胞疗法的人的安全也至关重要。埃默里输血和细胞疗法中心(CTCT)是美国最大、最全面的学术输血医学项目之一，致力于卓越的临床服务、杰出的基础、转换和临床研究，以及对该领域未来领导者的临床和研究培训。T32博士后科学家培训计划是为埃默里CTCT做出贡献并履行其使命的关键要素。如果得到资助，这笔赠款将继续为每年一名新的CTCT研究实习生提供工资支持，为期5年，参加为期2年的高度结构化、有指导的输血医学研究培训计划。我们的目标是满足公认的输血医学基础、翻译和跨学科研究培训的需求。需要这种培训来培养未来的输血、细胞治疗和移植研究方面的专家，以促进该专业的进一步增长和研究发展，并使其有能力为其他领域的研究和临床实践作出贡献。以前确定的计划优势包括：首席调查员/计划主任；将培训计划作为一个小规模计划组织起来，强调高质量的候选人和研究项目；拥有强大的科学、资金和培训记录的高级教员的参与；为教育研究员和对培训计划进行外部评估提供具体机制；以及以前支持的研究员的学术成功。为了进一步强调该项目致力于提供直接的个人努力来培训博士后研究员，教师导师仅限于那些在培训职业生涯早期研究人员方面拥有大量资金和经过证明的记录的人。该方案最初于2004年获得资助，并于2009年续签。我们现在正在申请第二次续签，将于2014年开始。到目前为止，已有7名学员完成了该计划，3名学员正在进行培训，1名学员已被指定开始培训。我们的T32研究员非常成功，这从手稿出版、教师任命、赠款支持和指导委员会审查中得到了证明。方案主任非常感谢为支持这项重要的培训工作而提供的资金，以及评审员在评估这项研究金时自愿付出的时间和努力。

DESCRIPTION (provided by applicant): This is a renewal NRSA application (T32 HL69769) requesting continued support to maintain an effective and productive Transfusion Medicine Research Training Fellowship at Emory University. Research in transfusion medicine is vital to the future of the field and, downstream, to the safety of recipients of transfusion and cellular therapies worldwide. The Emory Center for Transfusion and Cellular Therapies (CTCT) is one of the largest, most comprehensive academic transfusion medicine programs in the nation and is dedicated to excellence in clinical service, outstanding basic, translational and clinical research and the clinical and research-based training of future leaders in the field. The T32 Post-Doctoral Scientist Training Program is a critical element in both contributing to, and fulfilling the missio of, the Emory CTCT. If funded, this grant would continue to provide salary support for one new post-doctoral CTCT Research Trainee per year for a 5-year period to participate in a 2-year, highly structured, mentored training program in transfusion medicine research. We aim to fill the acknowledged need for basic, translational, and interdisciplinary research training in transfusion medicine. Such training is needed to develop future specialists in transfusion, cell therapy and transplantation research in order to contribute to the further growth and research development of the specialty and its ability to contribute to other fields of research and clinical practice. Program strengths previously identified include: the Principal Investigator/Program Director; the organization of the training plan as a small-scale program emphasizing high-quality candidates and research projects; the involvement of senior faculty with strong scientific, funding, and training records; the provision of specific mechanisms for educating fellows and externally evaluating the training program; and the academic successes of previously-supported Fellows. To further underscore the program's commitment to providing direct personal effort in training post-doctoral research fellows, the faculty mentors have been limited to only those with significant funding and proven track records in training early-career investigators. The Program was initially funded in 2004 and renewed in 2009. We are now applying for a second renewal to commence in 2014. To date, 7 Fellows have completed the program, 3 Fellows are in the middle of training, and 1 Fellow is designated to start. Our T32 Fellows have been highly successful as evidenced by manuscript publications, faculty appointments, grant support, and Steering Committee review. The Program Director greatly appreciates the funding that has been provided to support this important training effort, and the time and effort volunteered by the reviewers in evaluating this Fellowship.